Patient Knowledge of Individual Level of Risk Factor Control and Treatment Goals of Secondary Preventive Therapy in High Risk Patients with Cardiovascular Disease

Recruiting

• Conditions: I25; Chronic ischaemic heart disease

• Registration Number: DRKS00030703
• Lead Sponsor: Klinik für Kardiologie, Pneumologie und Angiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-11-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

1. Coronary artery disease
2. On prescription of high-potency statin (rosuvastatin or atorvastatin)

Exclusion Criteria

1. Hemodialysis
2. Dementia
3. No German language

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient knowledge of LDL-cholesterol, blood pressure, and HbA1c treatment goals.

Secondary Outcome Measures

Name	Time	Method
-Treatment goal attainment accordinng to ESC guideline (LDL-C, HbA1c, and blood pressure)<br><br>-Serum level of LDL-C and HbA1c, blood pressure<br><br>-Subjective level of information for ASCVD, dyslipidemia, arterial hypertension, and diabetes<br><br>-Information needs for ASCVD, dyslipidemia, arterial hypertension, and diabetes<br><br>-Duration since diagnose of ASCVD<br><br>-Adherence to drug therapy<br><br>-Perceived physician responsibility for of control risk facotrs and maintenance of secondary preventive therapy<br>